Skip to content

Study of Pulmonary Infections (Pneumonia) in Kidney Transplant Recipients Admitted to Hospital

Study of Pulmonary Infections (Pneumonia) in Kidney Transplant Recipients Admitted to Hospital

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05142748
Enrollment
132
Registered
2021-12-03
Start date
2019-09-01
Completion date
2020-11-30
Last updated
2022-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Transplant Infection

Brief summary

The investigators aimed to identify prognosis factors associated with in-hospital complications and assess the epidemiology, management, and outcomes of community-acquired pneumonia in a kidney transplant recipients' cohort. The investigators intend to identify each stay by a national database. Then they will be consulted by 2 clinicians to assert CAP clinical definition. After that radiographic evidence will be reviewed to validate CAP diagnoses. Then clinical data are collected in each center.

Interventions

None listed

Sponsors

CHU de Reims
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* kidney transplant recipients * at least 18 years * admitted to hospital for CAP. Non-inclusion criteria were:

Exclusion criteria

* incomplete CAP definition * hospital-acquired pneumonia * another diagnosis explaining the symptoms * patients with non-functional kidney graft

Design outcomes

Primary

MeasureTime frameDescription
In-hospital complicationsinhospital stay, an average of 30 daysIn-hospital death, transfer to intensive care units (ICU) and prolonged stays

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026